[go: up one dir, main page]

DE19854402A1 - Verwendung von Phosphonameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen - Google Patents

Verwendung von Phosphonameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen

Info

Publication number
DE19854402A1
DE19854402A1 DE19854402A DE19854402A DE19854402A1 DE 19854402 A1 DE19854402 A1 DE 19854402A1 DE 19854402 A DE19854402 A DE 19854402A DE 19854402 A DE19854402 A DE 19854402A DE 19854402 A1 DE19854402 A1 DE 19854402A1
Authority
DE
Germany
Prior art keywords
bacteria
group
substituted
radicals
family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19854402A
Other languages
German (de)
English (en)
Inventor
Hassan Jomaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jomaa Pharmaka GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19854402A priority Critical patent/DE19854402A1/de
Priority to TR2001/01433T priority patent/TR200101433T2/xx
Priority to IL14277699A priority patent/IL142776A0/xx
Priority to APAP/P/2001/002165A priority patent/AP2001002165A0/en
Priority to EA200100586A priority patent/EA200100586A1/ru
Priority to PL99348721A priority patent/PL348721A1/xx
Priority to OA1200100129A priority patent/OA11717A/en
Priority to CZ20011821A priority patent/CZ20011821A3/cs
Priority to AU15556/00A priority patent/AU1555600A/en
Priority to BR9915639-3A priority patent/BR9915639A/pt
Priority to CA002352549A priority patent/CA2352549A1/en
Priority to EP99958099A priority patent/EP1131075A2/de
Priority to CN99813703A priority patent/CN1328465A/zh
Priority to PCT/EP1999/008965 priority patent/WO2000030625A2/de
Priority to JP2000583508A priority patent/JP2002530326A/ja
Publication of DE19854402A1 publication Critical patent/DE19854402A1/de
Priority to NO20012541A priority patent/NO20012541L/no
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE19854402A 1998-11-25 1998-11-25 Verwendung von Phosphonameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen Ceased DE19854402A1 (de)

Priority Applications (16)

Application Number Priority Date Filing Date Title
DE19854402A DE19854402A1 (de) 1998-11-25 1998-11-25 Verwendung von Phosphonameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen
CZ20011821A CZ20011821A3 (cs) 1998-11-25 1999-11-20 Použití derivátů kyseliny fosfonomravenčí k ošetřování infekcí
CA002352549A CA2352549A1 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
APAP/P/2001/002165A AP2001002165A0 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
EA200100586A EA200100586A1 (ru) 1998-11-25 1999-11-20 Применение производных фосфономуравьиной кислоты для лечения инфекций
PL99348721A PL348721A1 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
OA1200100129A OA11717A (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections.
TR2001/01433T TR200101433T2 (tr) 1998-11-25 1999-11-20 Enfeksiyonların tedavisinde fosfonoformik asit türevlerinin kullanımı.
AU15556/00A AU1555600A (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
BR9915639-3A BR9915639A (pt) 1998-11-25 1999-11-20 Uso de derivados de ácido fosfonofórmico para o tratamento de infecções
IL14277699A IL142776A0 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
EP99958099A EP1131075A2 (de) 1998-11-25 1999-11-20 Verwendung von phosphonoameisensäurederivaten zur behandlung von infektionen
CN99813703A CN1328465A (zh) 1998-11-25 1999-11-20 膦酰基甲酸衍生物治疗感染的用途
PCT/EP1999/008965 WO2000030625A2 (de) 1998-11-25 1999-11-20 Verwendung von phosphonoameisensäurederivaten zur behandlung von infektionen
JP2000583508A JP2002530326A (ja) 1998-11-25 1999-11-20 感染症の治療のためのホスホノ蟻酸誘導体の使用
NO20012541A NO20012541L (no) 1998-11-25 2001-05-23 Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19854402A DE19854402A1 (de) 1998-11-25 1998-11-25 Verwendung von Phosphonameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen

Publications (1)

Publication Number Publication Date
DE19854402A1 true DE19854402A1 (de) 2000-05-31

Family

ID=7888997

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19854402A Ceased DE19854402A1 (de) 1998-11-25 1998-11-25 Verwendung von Phosphonameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen

Country Status (16)

Country Link
EP (1) EP1131075A2 (pt)
JP (1) JP2002530326A (pt)
CN (1) CN1328465A (pt)
AP (1) AP2001002165A0 (pt)
AU (1) AU1555600A (pt)
BR (1) BR9915639A (pt)
CA (1) CA2352549A1 (pt)
CZ (1) CZ20011821A3 (pt)
DE (1) DE19854402A1 (pt)
EA (1) EA200100586A1 (pt)
IL (1) IL142776A0 (pt)
NO (1) NO20012541L (pt)
OA (1) OA11717A (pt)
PL (1) PL348721A1 (pt)
TR (1) TR200101433T2 (pt)
WO (1) WO2000030625A2 (pt)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037290A1 (en) * 2003-10-20 2005-04-28 Council Of Scientific And Industrial Research Use of phosphono derivatives as anti-malarial
US9808011B2 (en) 2014-12-15 2017-11-07 Biovectra Inc. Pentacyclic triterpene compounds and uses thereof

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004218880A1 (en) * 2003-03-14 2004-09-23 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
CN105794493A (zh) * 2016-03-11 2016-07-27 钦州市凤源泉生物科技有限公司 一种提高红椎菌主要活性成分的培养方法
KR101912774B1 (ko) 2016-11-21 2018-10-29 한국식품연구원 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
KR101797926B1 (ko) * 2016-11-21 2017-11-15 한국식품연구원 포름산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
CN108948005A (zh) * 2018-07-03 2018-12-07 湖南华腾制药有限公司 聚乙二醇修饰的依诺沙星及应用
KR102641583B1 (ko) * 2018-10-23 2024-02-28 건국대학교 산학협력단 지도부딘을 포함하는 식물병 방제용 조성물
CN114983999A (zh) * 2022-06-09 2022-09-02 四川大学 一种青蒿素及其衍生物的新用途、验证方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603726D0 (sv) * 1996-10-11 1996-10-11 Astra Ab Novel compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037290A1 (en) * 2003-10-20 2005-04-28 Council Of Scientific And Industrial Research Use of phosphono derivatives as anti-malarial
US9808011B2 (en) 2014-12-15 2017-11-07 Biovectra Inc. Pentacyclic triterpene compounds and uses thereof

Also Published As

Publication number Publication date
EA200100586A1 (ru) 2001-12-24
OA11717A (en) 2005-01-26
EP1131075A2 (de) 2001-09-12
WO2000030625A3 (de) 2000-10-05
JP2002530326A (ja) 2002-09-17
AU1555600A (en) 2000-06-13
NO20012541D0 (no) 2001-05-23
BR9915639A (pt) 2001-08-07
PL348721A1 (en) 2002-06-03
NO20012541L (no) 2001-07-24
WO2000030625A2 (de) 2000-06-02
CA2352549A1 (en) 2000-06-02
CZ20011821A3 (cs) 2001-09-12
AP2001002165A0 (en) 2001-06-30
IL142776A0 (en) 2002-03-10
CN1328465A (zh) 2001-12-26
TR200101433T2 (tr) 2001-10-22

Similar Documents

Publication Publication Date Title
EP1071409B1 (de) Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
DE19903398A1 (de) Verwendung von Thiadiazolderivaten zur prophylaktischen und therapeutischen Behandlung von Infektionen
WO2000004031A1 (de) Phosphororganische verbindungen und ihre verwendung
DE19920247A1 (de) Arzneimittel mit einem Gehalt an Verbindungen mit einem Stickstoff-Sauerstoff-Heterocyclus als Wirkstoff und ihre Verwendung
DE19854402A1 (de) Verwendung von Phosphonameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen
DE19859426A1 (de) Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen
EP0655249B1 (de) Moenomycin als Arzneimittel zur Behandlung von Magengeschwüren
EP1133500B1 (de) Phosphororganische verbindungen und ihre verwendung
DE19843383A1 (de) Phosphororganische Verbindungen und ihre Verwendung
DE19843222A1 (de) Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen
DE19902924A1 (de) Verwendung von phosphororganischen Verbindungen zur prophylaktischen und therapeutischen Behandlung von Infektionen
DE19854310A1 (de) Verwendung von Phosphonoameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen
DE19843223A1 (de) Phosphororganische Verbindungen und ihre Verwendung
DE10014127A1 (de) Verwendung von phosphororganischen Verbindungen zur Behandlung von Infektionen
EP1143941A2 (de) Verwendung von 3-isoxazolidinonen und hydroxylaminsäuren zur behandlung von infektionen
DE19843334A1 (de) Schwefelorganische Verbindungen und ihre Verwendung
DE19859668A1 (de) Verwendung von Bisphosphonaten zur Prophylaxe und zur Behandlung von infektiösen Prozessen
DE19903666A1 (de) Arzneimittel mit einem Gehalt an 3-Isoxazolidinonen und Hydroxylaminsäuren als Wirkstoff und ihre Verwendung
WO2004019956A1 (de) Phosphororganische verbindungen zur behandlung von helminthen infektionen

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8127 New person/name/address of the applicant

Owner name: JOMAA PHARMAKA GMBH, 35392 GIESSEN, DE

8181 Inventor (new situation)

Free format text: JOMAA, HASSAN, DR., 35398 GIESSEN, DE

8131 Rejection